enGene Holdings Inc.

Healthcare

NASDAQ:ENGN · NASDAQ Capital Market

Market Cap $89.08M Beta -0.29 P/E (TTM) -1.8

$1.72 -1.15%

-$0.02 today

52W Low $1.40High $12.25

Vol 0.89M · Avg 1.58M

EPS (TTM) -$0.95Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-43.05%

Period High

$12.17

Period Low

$1.44

Latest

$1.72

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Alto Neuroscience, Inc.

NYSE:ANRO

$795.58M

Annexon, Inc.

NASDAQ:ANNX

$591.40M

DBV Technologies S.A.

NASDAQ:DBVT

$379.28M

Amarin Corporation plc

NASDAQ:AMRN

$335.06M

Silence Therapeutics plc

NASDAQ:SLN

$321.13M

Cellectis S.A.

NASDAQ:CLLS

$308.78M

Larimar Therapeutics, Inc.

NASDAQ:LRMR

$307.08M

AC Immune S.A.

NASDAQ:ACIU

$243.75M

Altimmune, Inc.

NASDAQ:ALT

$241.87M

Korro Bio, Inc.

NASDAQ:KRRO

$127.35M

What is the latest ENGN filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does ENGN have?

Intrinsic Alpha currently shows 20 recent filings for ENGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.